Dear dupa,

The top of the biopharmaceutical world is changing. New biotechs are ascendant. Legacy pharma players seem stuck — or in decline. The rise of China has just begun, and the US has no answer yet. Tech-first AI companies are in a race against old powers to own the future of drug development. 

In January at the JP Morgan Healthcare Conference, our journalists will lead a dialogue on this change — who’s rising, who’s falling and how the drug business will look very different at the end of the decade.

We’ve already booked keynote interviews with some of the people at the forefront of this change, and we hope to see you for conversations you won’t get anywhere else. And when you need a moment to reflect and talk about what you’ve learned, the Endpoints Hub will give you a place to step back from the frenzy, to meet and to connect.

See you there,